A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report

Capecitabine is an oral fluoropyrimidine which can prolong QT interval. However, there have been no reports that capecitabine induced ventricular fibrillation (VF) due to secondary QT prolongation in patients with no structural heart disease. A 39-year-old woman developed VF during the chemotherapy...

詳細記述

保存先:
書誌詳細
出版年:J Cardiol Cases
主要な著者: Hayasaka, Kazuto, Takigawa, Masateru, Takahashi, Atsushi, Kuwahara, Taishi, Okubo, Kenji, Tanaka, Yasuaki, Misawa, Toru, Mizusawa, Masafumi, Yamakami, Yosuke, Kojima, Keisuke, Sagawa, Yuichiro, Hishikari, Keiichi, Yamao, Kazuya, Nakashima, Emiko, Nakajima, Jun, Kimura, Shigeki, Takagi, Katsumasa, Hikita, Hiroyuki, Isobe, Mitsuaki
フォーマット: Artigo
言語:Inglês
出版事項: Japanese College of Cardiology 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149258/
https://ncbi.nlm.nih.gov/pubmed/30279790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2017.03.009
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料